Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Breast Neoplasms"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22ClinicalTrials.gov%22&type=JournalTitle&filter%5B%5D=topic_facet%3A%22Breast+Neoplasms%22
/vufind/Search/Results?lookfor=%22ClinicalTrials.gov%22&type=JournalTitle&filter%5B%5D=topic_facet%3A%22Breast+Neoplasms%22
Search /vufind/Search2/Results?lookfor=%22ClinicalTrials.gov%22&type=JournalTitle&filter%5B%5D=topic_facet%3A%22Breast+Neoplasms%22
PubPharm (10.204)
1
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial : Molecular Analysis for Combination Therapy Choice (ComboMATCH)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
FH-Risk 2.0: Updating Breast Cancer Risk Estimates : Recalculating Breast Cancer Risk and Exploring the Experience of Receiving Updated Breast Cancer Risk Estimates in Women With a Family History of Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Patients With Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial : Phase 1/1B Study of DS-8201a in Combination With ATR Inhibition (AZD6738) in Advanced Solid Tumors With HER2 Expression (DASH Trial)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study : Open-label, Safety Extension Study for Subjects With HR+, HER2-Negative Breast Cancer Who Have Completed the OVarian Suppression Evaluating Subcutaneous LeuprolIde Acetate in Breast Cancer OVELIA Study
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer : Phase 3,Single Arm,Open-Label Study Evaluating Ovarian Suppression Following 3 Month Leuprolide Acetate For Injectable Suspension (TOL2506) in Combination With Endocrine Therapy in Premenopausal Subjects With Hormone-Receptor-Positive (HR+),Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment : AN INTERVENTIONAL, OPEN-LABEL, RANDOMIZED, MULTICENTER PHASE 3 STUDY OF PF-07220060 PLUS FULVESTRANT COMPARED TO INVESTIGATOR'S CHOICE OF THERAPY IN PARTICIPANTS OVER 18 YEARS OF AGE WITH HORMONE RECEPTOR-POSITIVE, HER2-NEGATIVE ADVANCED/METASTATIC BREAST CANCER WHOSE DISEASE PROGRESSED AFTER PRIOR CDK 4/6 INHIBITOR-BASED THERAPY
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Study to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid Tumors : Phase 1/2, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, and Preliminary Antitumor Activity of TNG348 Single Agent and in Combination With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or Other HRD+ Solid Tumors
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Optimizing a mHealth Physical Activity Intervention With Mindful Awareness Lessons in Breast Cancer Survivors : Fit2ThriveMIND: Optimizing a mHealth Physical Activity Intervention With Mindful Awareness Lessons in Breast Cancer Survivors
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease : SERENA-4: A Randomised, Multicentre, Double-Blind, Phase III Study of AZD9833 (an Oral SERD) Plus Palbociclib Versus Anastrozole Plus Palbociclib for the Treatment of Patients With Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer : Phase IB Trial of Niraparib and TSR-042 in Patients With BRCA-Mutated Breast, Pancreas or Ovary Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[1021]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Breast Neoplasms
Medienart
10.204
Aufsätze
10.204
E-Artikel
10.204
E-Ressourcen
Zeitschriftentitel
10.204
ClinicalTrials.gov
Thema
Breast Neoplasms
10.203
610
8.056
Study Type: Interventional
4.261
Recruitment Status: Completed
2.578
Medical Condition: Breast Cancer
2.510
Phase: Phase 2
2.261
Recruitment Status: Recruiting
2.067
Study Type: Observational
1.098
Recruitment Status: Active, not recruiting
960
Phase: Phase 3
906
Phase: Phase 1
840
Recruitment Status: Terminated
726
Triple Negative Breast Neoplasms
679
Recruitment Status: Unknown status
597
Recruitment Status: Not yet recruiting
509
Carcinoma
389
Neoplasms
355
Medical Condition: Metastatic Breast Cancer
342
Recruitment Status: Withdrawn
298
Medical Condition: Breast Neoplasms
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
6.284
2020-
3.712
2010-2019
208
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
10.204
Englisch
Haven't found what you're looking for?
Wird geladen...